Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

12.98
Delayed Data
As of Dec 12
 -0.18 / -1.37%
Today’s Change
4.41
Today|||52-Week Range
16.60
+161.17%
Year-to-Date
No recent news for Amicus Therapeutics Inc.

Today’s Trading

Previous close13.16
Today’s open13.21
Day’s range12.92 - 13.33
Volume1,577,889
Average volume (3 months)2,976,310
Market cap$2.2B
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-24.17%
Earnings growth (this year)--
Earnings growth (next 5 years)-57.25%
Revenue growth (last year)--
P/E ratioNM
Price/Sales134.73
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.30+1.96%
RAREUltragenyx Pharmaceu...-0.73-1.61%
LOXOLoxo Oncology Inc-1.62-1.92%
SUPNSupernus Pharmaceuti...+0.20+0.53%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$5.0M
Annual profit (last year)-$200.0M
Net profit margin-4,034.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts